Table 3.
Case | PVL (copies/100 PBMCs) |
Tax tetramer+ T cells in CD8+ T cells (%) | Tax+ T cells in CD4+ T cells (%) | IFN-γ+ T cells in CD8+ T-cells (%) | ||||
---|---|---|---|---|---|---|---|---|
Whole cells | CD8-depleted PBMCs | Fold change | Whole cells | CD4-depleted PBMCs | Fold change | |||
RD2 | 9.01 | 21.4 | 1.06 | 3.85 | 3.63 | 4.14 | 0.22 | 0.05 |
RD1 | 19.1 | 18.2 | 3.63 | 7.06 | 1.94 | 7.26 | 0.22 | 0.03 |
RD4 | 3.59 | 11.4 | 0.16 | 4.13 | 25.8 | 2.76 | 0.11 | 0.04 |
RD5 | 6.14 | 5.10 | 10.3 | 9.96 | 0.97 | 2.73 | 0.54 | 0.20 |
RD3 | 8.32 | 4.73 | 13.6 | 8.62 | 0.63 | 2.15 | 0.06 | 0.03 |
RD, rheumatic disease; PVL, proviral load; PBMCs, peripheral blood mononuclear cells.